Yahoo Web Search

    • VKTX: Multiple Milestones Upcoming in 2021…

      Zacks Small Cap Research via Yahoo Finance· 3 months ago

      A key secondary outcome measure is histological changes assessed by liver biopsy following 52 weeks of dosing. During our call, management indicated that...

    • VKTX: Phase2b Trial of VK2809 Underway…

      Zacks Small Cap Research via Yahoo Finance· 1 year ago

      On November 19, 2019, Viking Therapeutics, Inc. (NASDAQ:VKTX) announced that the Phase 2b VOYAGE trial of VK2809 in patients with biopsy-confirmed...